Aug 2026· Molecular Metabolism· Vol 113, pp. 102433· 1 citation· 97 references
Medicine
TL;DR
The glucagon–PDE2A–PKA–NCLX signaling axis is established as a key metabolic rheostat integrating mitochondrial calcium dynamics with lipid homeostasis, providing a promising therapeutic target for MASLD.
Abstract
Mitochondrial calcium signaling, particularly its glucagon-mediated oscillatory dynamics, plays a pivotal role in regulating hepatic metabolism and is known to be disrupted in steatotic liver disease. We recently identified the mitochondrial Na+/Ca2+exchanger NCLX as a key mediator of glucagon-induced mitochondrial calcium oscillations, essential for proper gluconeogenic function. Here, using hepatocyte-specific NCLX knockout (cKO) mice, we demonstrate that NCLX is critical for intrahepatic lipolysis and fatty acid oxidation (FAO); its loss impairs glucagon-stimulated lipid droplet catabolism and blunts FAO. Mechanistically, we find that NCLX deficiency disrupts allosteric activation of lipolytic enzymes and increases CPT1 sensitivity to malonyl-CoA-mediated inhibition, resulting in defective lipolysis and FAO. We further show that glucagon regulates hepatic NCLX via cAMP/PKA-dependent phosphorylation at NCLX Ser258. Notably, PDE2A acts as a negative regulator of this pathway by degrading mitochondrial cAMP. Hepatic mitochondrial PDE2A abundance and cAMP-degrading activity are elevated in HFD, and in vivo BAY 60-7550 treatment suppresses mitochondrial cAMP degradation and augments PKA signaling in steatotic livers. Pharmacologic inhibition of PDE2A with BAY 60-7550 enhances NCLX phosphorylation, restores mitochondrial calcium efflux and oscillations, and stimulates FAO in an NCLX-dependent manner. Importantly, we uncover that cAMP/PKA-dependent phosphorylation of NCLX at Ser258 is suppressed in human steatotic livers, and that pharmacologic inhibition of PDE2A ameliorates hepatic FAO and steatosis in both dietary and genetic MASLD models. Collectively, our findings establish the glucagon–PDE2A–PKA–NCLX signaling axis as a key metabolic rheostat integrating mitochondrial calcium dynamics with lipid homeostasis, providing a promising therapeutic target for MASLD.
Adenosine 5’-monophosphate−activated protein kinase (AMPK), a highly conserved energy-sensing kinase, plays a central role in maintaining cellular metabolic homeostasis, such as glucose/lipid metabolism, mitochondrial biogenesis, and autophagy, to counteract energetic stress. Beyond the canonical adenylate-dependent ac...
Zheng-Kui Zhang, Yuan-Zhuo Gu, Hong-Chao He et al.· Signal Transduction and Targ...· 0 citations
Glucagon-like peptide-1 (GLP-1) receptor agonists have become revolutionary therapies against metabolic dis-
eases, obesity, and even neurological disorders. In addition to its role as an incretin hormone, GLP-1 is involved
in modulating mitochondria energetics and the cellular redox status through direct actions. The...
George B. Stefano· Biomedical Journal of Scient...· 0 citations
Intracellular Ca2+ signaling is essential for glucose-induced insulin secretion (GIIS) and hepatic glucose production (HGP), yet how Ca2+ dynamics are coordinated across organs remains unclear. Carbonic anhydrase VIII (CA8), an endogenous inhibitor of inositol 1,4,5-trisphosphate receptor 1 (IP3R1), was identified as a...
Muhammad Fauzi, Takaaki Murakami, Ryota Usui et al.· Science Advances· 0 citations
A PPARγ-like signalling axis that integrates sphingolipid metabolism, organelle quality control, and neuronal homeostasis is identified, providing a mechanistic framework for understanding how metabolic regulation promotes neuroprotection.
Dikaia Tsagkari, Maria Markaki, Tao Zhang et al.· bioRxiv· 0 citations
The mechanism underlying the role of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) in metabolic disease remains unsolved. Using a 2'3'-cyclic GMP-AMP (cGAMP)-hydrolysis-deficient mouse (Enpp1H362A), we show that selective loss of this activity exacerbates high-fat diet (HFD)-induced weight gain and insulin...
Song-Nan Wang, Ying-Jie Guo, Wei-Dong An et al.· Cell Reports· 0 citations
AMP-activated protein kinase (AMPK) is widely examined in diabetic cardiomyopathy (DCM) through total protein abundance and activation-loop phosphorylation, typically reported as
p
-AMPK
Thr172
. Yet these measurements cannot identify the active
αβγ
heterotrimer, cellular source, intracellular location, or regu...